CLINICAL_TRIALS
trial_result
· 2015-06-17
Clinical Trial Update: BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) [Phase 2]
Summary
Phase 2 trial update for PSMA-targeted approach in glioblastoma multiforme (GBM) showing completed results as of 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Heinrich Elinzano, MD | Conditions: GBM, Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2015-06-17